{"id":10993,"date":"2019-08-09T16:48:34","date_gmt":"2019-08-09T16:48:34","guid":{"rendered":"http:\/\/drupal.test\/projects\/mise-au-point-danalyses-de-pd-l1-de-nouvelle-generation-laise-de-la-spectrometrie-de-masse-de\/"},"modified":"2022-07-26T13:13:33","modified_gmt":"2022-07-26T17:13:33","slug":"mise-au-point-danalyses-de-pd-l1-de-nouvelle-generation-laise-de-la-spectrometrie-de-masse-de","status":"publish","type":"project","link":"https:\/\/dev.genomecanada.ca\/fr\/project\/mise-au-point-danalyses-de-pd-l1-de-nouvelle-generation-laise-de-la-spectrometrie-de-masse-de\/","title":{"rendered":"Mise au point d\u2019analyses de PD-L1 de nouvelle g\u00e9n\u00e9ration \u00e0 l\u2019aise de la spectrom\u00e9trie de masse de pr\u00e9cision"},"content":{"rendered":"<p>Le cancer du poumon compte pour 14 % de tous les cancers diagnostiqu\u00e9s au Canada, et 80 % des patients atteints seront soumis \u00e0 une analyse de la prot\u00e9ine 1 de mort cellulaire programm\u00e9e (PD-L1) pendant le cours de leur maladie. Ce projet vise \u00e0 mettre au point des analyses de PD-L1 fond\u00e9es sur la spectrom\u00e9trie de masse en vue d\u2019une utilisation en immuno-oncologie. Le r\u00e9cepteur, MRM Proteomics, en partenariat avec les responsables universitaires, d\u00e9veloppera deux proc\u00e9d\u00e9s d\u2019analyse distincts en se fondant sur la surveillance de r\u00e9actions multiples, \u00e0 des fins de recherche et la technologie immuno-MALDI (iMALDI), \u00e0 des fins de diagnostic clinique. Les revenus anticip\u00e9s provenant de la nouvelle trousse d\u2019analyse de PD-L1 de MRM Proteomics s\u2019\u00e9l\u00e8vent \u00e0 3,5 millions de dollars sur les cinq premi\u00e8res ann\u00e9es suivant le projet; l\u2019ajout de la technologie iMALDI \u00e0 20 % des trousses d\u2019analyse de PD-L1 existantes g\u00e9n\u00e9rerait plus de 250 millions de dollars.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Le cancer du poumon compte pour 14 % de tous les cancers diagnostiqu\u00e9s au Canada, et 80 % des patients atteints seront soumis \u00e0 une analyse de la prot\u00e9ine 1 de mort cellulaire programm\u00e9e (PD-L1) pendant le cours de leur maladie. Ce projet vise \u00e0 mettre au point des analyses de PD-L1 fond\u00e9es sur la [&hellip;]<\/p>\n","protected":false},"featured_media":0,"template":"","meta":{"_acf_changed":false,"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}}},"project-categories":[92],"genome-competitions":[210],"project-sector":[],"genome_centres":[104],"class_list":["post-10993","project","type-project","status-publish","hentry","project-categories-translation-fr","genome-competitions-programme-de-partenariats-pour-les-applications-de-la-genomique","genome_centres-genome-quebec-fr"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Mise au point d\u2019analyses de PD-L1 de nouvelle g\u00e9n\u00e9ration \u00e0 l\u2019aise de la spectrom\u00e9trie de masse de pr\u00e9cision - GenomeCanada<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Mise au point d\u2019analyses de PD-L1 de nouvelle g\u00e9n\u00e9ration \u00e0 l\u2019aise de la spectrom\u00e9trie de masse de pr\u00e9cision - GenomeCanada\" \/>\n<meta property=\"og:description\" content=\"Le cancer du poumon compte pour 14 % de tous les cancers diagnostiqu\u00e9s au Canada, et 80 % des patients atteints seront soumis \u00e0 une analyse de la prot\u00e9ine 1 de mort cellulaire programm\u00e9e (PD-L1) pendant le cours de leur maladie. Ce projet vise \u00e0 mettre au point des analyses de PD-L1 fond\u00e9es sur la [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/dev.genomecanada.ca\/fr\/project\/mise-au-point-danalyses-de-pd-l1-de-nouvelle-generation-laise-de-la-spectrometrie-de-masse-de\/\" \/>\n<meta property=\"og:site_name\" content=\"GenomeCanada\" \/>\n<meta property=\"article:modified_time\" content=\"2022-07-26T17:13:33+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/dev.genomecanada.ca\\\/fr\\\/project\\\/mise-au-point-danalyses-de-pd-l1-de-nouvelle-generation-laise-de-la-spectrometrie-de-masse-de\\\/\",\"url\":\"https:\\\/\\\/dev.genomecanada.ca\\\/fr\\\/project\\\/mise-au-point-danalyses-de-pd-l1-de-nouvelle-generation-laise-de-la-spectrometrie-de-masse-de\\\/\",\"name\":\"Mise au point d\u2019analyses de PD-L1 de nouvelle g\u00e9n\u00e9ration \u00e0 l\u2019aise de la spectrom\u00e9trie de masse de pr\u00e9cision - GenomeCanada\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/dev.genomecanada.ca\\\/fr\\\/#website\"},\"datePublished\":\"2019-08-09T16:48:34+00:00\",\"dateModified\":\"2022-07-26T17:13:33+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/dev.genomecanada.ca\\\/fr\\\/project\\\/mise-au-point-danalyses-de-pd-l1-de-nouvelle-generation-laise-de-la-spectrometrie-de-masse-de\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/dev.genomecanada.ca\\\/fr\\\/project\\\/mise-au-point-danalyses-de-pd-l1-de-nouvelle-generation-laise-de-la-spectrometrie-de-masse-de\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/dev.genomecanada.ca\\\/fr\\\/project\\\/mise-au-point-danalyses-de-pd-l1-de-nouvelle-generation-laise-de-la-spectrometrie-de-masse-de\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/dev.genomecanada.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Mise au point d\u2019analyses de PD-L1 de nouvelle g\u00e9n\u00e9ration \u00e0 l\u2019aise de la spectrom\u00e9trie de masse de pr\u00e9cision\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/dev.genomecanada.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/dev.genomecanada.ca\\\/fr\\\/\",\"name\":\"GenomeCanada\",\"description\":\"Harnessing the transformative power of genomics\",\"publisher\":{\"@id\":\"https:\\\/\\\/dev.genomecanada.ca\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/dev.genomecanada.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/dev.genomecanada.ca\\\/fr\\\/#organization\",\"name\":\"GenomeCanada\",\"url\":\"https:\\\/\\\/dev.genomecanada.ca\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/dev.genomecanada.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/dev.genomecanada.ca\\\/wp-content\\\/uploads\\\/2021\\\/07\\\/genome-canada_stacked.svg\",\"contentUrl\":\"https:\\\/\\\/dev.genomecanada.ca\\\/wp-content\\\/uploads\\\/2021\\\/07\\\/genome-canada_stacked.svg\",\"width\":285,\"height\":180,\"caption\":\"GenomeCanada\"},\"image\":{\"@id\":\"https:\\\/\\\/dev.genomecanada.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Mise au point d\u2019analyses de PD-L1 de nouvelle g\u00e9n\u00e9ration \u00e0 l\u2019aise de la spectrom\u00e9trie de masse de pr\u00e9cision - GenomeCanada","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"fr_FR","og_type":"article","og_title":"Mise au point d\u2019analyses de PD-L1 de nouvelle g\u00e9n\u00e9ration \u00e0 l\u2019aise de la spectrom\u00e9trie de masse de pr\u00e9cision - GenomeCanada","og_description":"Le cancer du poumon compte pour 14 % de tous les cancers diagnostiqu\u00e9s au Canada, et 80 % des patients atteints seront soumis \u00e0 une analyse de la prot\u00e9ine 1 de mort cellulaire programm\u00e9e (PD-L1) pendant le cours de leur maladie. Ce projet vise \u00e0 mettre au point des analyses de PD-L1 fond\u00e9es sur la [&hellip;]","og_url":"https:\/\/dev.genomecanada.ca\/fr\/project\/mise-au-point-danalyses-de-pd-l1-de-nouvelle-generation-laise-de-la-spectrometrie-de-masse-de\/","og_site_name":"GenomeCanada","article_modified_time":"2022-07-26T17:13:33+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/dev.genomecanada.ca\/fr\/project\/mise-au-point-danalyses-de-pd-l1-de-nouvelle-generation-laise-de-la-spectrometrie-de-masse-de\/","url":"https:\/\/dev.genomecanada.ca\/fr\/project\/mise-au-point-danalyses-de-pd-l1-de-nouvelle-generation-laise-de-la-spectrometrie-de-masse-de\/","name":"Mise au point d\u2019analyses de PD-L1 de nouvelle g\u00e9n\u00e9ration \u00e0 l\u2019aise de la spectrom\u00e9trie de masse de pr\u00e9cision - GenomeCanada","isPartOf":{"@id":"https:\/\/dev.genomecanada.ca\/fr\/#website"},"datePublished":"2019-08-09T16:48:34+00:00","dateModified":"2022-07-26T17:13:33+00:00","breadcrumb":{"@id":"https:\/\/dev.genomecanada.ca\/fr\/project\/mise-au-point-danalyses-de-pd-l1-de-nouvelle-generation-laise-de-la-spectrometrie-de-masse-de\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/dev.genomecanada.ca\/fr\/project\/mise-au-point-danalyses-de-pd-l1-de-nouvelle-generation-laise-de-la-spectrometrie-de-masse-de\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/dev.genomecanada.ca\/fr\/project\/mise-au-point-danalyses-de-pd-l1-de-nouvelle-generation-laise-de-la-spectrometrie-de-masse-de\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/dev.genomecanada.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Mise au point d\u2019analyses de PD-L1 de nouvelle g\u00e9n\u00e9ration \u00e0 l\u2019aise de la spectrom\u00e9trie de masse de pr\u00e9cision"}]},{"@type":"WebSite","@id":"https:\/\/dev.genomecanada.ca\/fr\/#website","url":"https:\/\/dev.genomecanada.ca\/fr\/","name":"GenomeCanada","description":"Harnessing the transformative power of genomics","publisher":{"@id":"https:\/\/dev.genomecanada.ca\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dev.genomecanada.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/dev.genomecanada.ca\/fr\/#organization","name":"GenomeCanada","url":"https:\/\/dev.genomecanada.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/dev.genomecanada.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/dev.genomecanada.ca\/wp-content\/uploads\/2021\/07\/genome-canada_stacked.svg","contentUrl":"https:\/\/dev.genomecanada.ca\/wp-content\/uploads\/2021\/07\/genome-canada_stacked.svg","width":285,"height":180,"caption":"GenomeCanada"},"image":{"@id":"https:\/\/dev.genomecanada.ca\/fr\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/dev.genomecanada.ca\/fr\/wp-json\/wp\/v2\/project\/10993","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dev.genomecanada.ca\/fr\/wp-json\/wp\/v2\/project"}],"about":[{"href":"https:\/\/dev.genomecanada.ca\/fr\/wp-json\/wp\/v2\/types\/project"}],"version-history":[{"count":0,"href":"https:\/\/dev.genomecanada.ca\/fr\/wp-json\/wp\/v2\/project\/10993\/revisions"}],"wp:attachment":[{"href":"https:\/\/dev.genomecanada.ca\/fr\/wp-json\/wp\/v2\/media?parent=10993"}],"wp:term":[{"taxonomy":"project-categories","embeddable":true,"href":"https:\/\/dev.genomecanada.ca\/fr\/wp-json\/wp\/v2\/project-categories?post=10993"},{"taxonomy":"genome-competitions","embeddable":true,"href":"https:\/\/dev.genomecanada.ca\/fr\/wp-json\/wp\/v2\/genome-competitions?post=10993"},{"taxonomy":"project-sector","embeddable":true,"href":"https:\/\/dev.genomecanada.ca\/fr\/wp-json\/wp\/v2\/project-sector?post=10993"},{"taxonomy":"genome_centres","embeddable":true,"href":"https:\/\/dev.genomecanada.ca\/fr\/wp-json\/wp\/v2\/genome_centres?post=10993"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}